What is Evommune 's current ratio?

Evommune (EVMN) reported current ratio of 1.2× in Q1 2026.

What does current ratio mean?

Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.

Evommune EVMN Current ratio

Current ratio at other companies

PfizerPFE

1.2×0.0×

Bausch + LombBLCO

1.5×0.0×

BillionToOne, Inc. BLLN

10.9×—

Perrigo CompanyPRGO

2.7×+0.4×

Hims & Hers HealthHIMS

1.7×+0.1×

Other financials

Income statement

See full

Revenue$1.6M+3.5%

Gross profit$961.1K+10.9%

Operating income-$682.8K-2,027%

Net income-$7.0M-5,414%

EPS (diluted)-$0.36-1,700%

Balance sheet

See full

Cash & equivalents$1.1M+401%

Total debt$2.0M—

Total equity-$4.5M-3,048%

Total assets$7.2M—

Cash flow

See full

Operating cash flow-$424.6K-341%

CapEx$1.0-99.8%

Free cash flow-$2.7M-4,996%

Valuation

See full

Market cap$848.59M+39.5%

Enterprise value$849.52M—

P/S127.3×—

Profitability

See full

Gross margin53.7%—

Operating margin-30.7%—

Net margin-90.1%—

Returns & leverage

See full

Return on equity275.7%—

Debt / equity1.4×—

Where this comes from

Calculated from Evommune ’s reported figures.

total current assets/total current liabilities=1.2×

Based on the most recent quarter.

The official record: Evommune ’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →

Ask your AI about Evommune 's current ratio.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Evommune 's current ratio?: Evommune (EVMN) reported current ratio of 1.2× in Q1 2026.
What does current ratio mean?: Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.